DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

RBC Capital Upgrades Biomarin Pharmaceutical to Sector Outperform

RBC Capital analyst Kennen MacKay upgrades Biomarin Pharmaceutical (NASDAQ:BMRN) from Sector Perform to Sector Outperform.

Benzinga · 01/24/2020 11:51

RBC Capital analyst Kennen MacKay upgrades Biomarin Pharmaceutical (NASDAQ:BMRN) from Sector Perform to Sector Outperform.